Cargando…

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

PURPOSE: Whereas anti-oestrogen therapy is widely applied to treat oestrogen receptor (ER) positive breast cancer, paradoxically, oestrogens can also induce tumour regression. Up-regulation of ER expression is a marker for oestrogen hypersensitivity. We, therefore, performed an exploratory study to...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Kruchten, Michel, Glaudemans, Andor W. J. M., de Vries, Erik F. J., Schröder, Carolien P., de Vries, Elisabeth G. E., Hospers, Geke A. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554736/ https://www.ncbi.nlm.nih.gov/pubmed/26091705 http://dx.doi.org/10.1007/s00259-015-3107-5

Ejemplares similares

Molecular imaging as biomarker for treatment response and outcome in breast cancer
por: van Geel, Jasper J. L., et al.
Publicado: (2023)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

Image Quality and Interpretation of [(18)F]-FES-PET: Is There any Effect of Food Intake?
por: Boers, Jorianne, et al.
Publicado: (2020)

18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis
por: Matushita, Cristina S., et al.
Publicado: (2023)

Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis
por: Mo, Jin A
Publicado: (2021)

Enhanced pulmonary uptake on (18)F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?
por: Venema, C. M., et al.
Publicado: (2019)

Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021)

Visual and quantitative evaluation of [(18)F]FES and [(18)F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
por: Mammatas, Lemonitsa H., et al.
Publicado: (2020)

Can (18)F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with (18)F-Fluorodeoxyglucose Positron Emission Tomography?
por: Gupta, Manoj, et al.
Publicado: (2017)

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
por: van de Donk, Pim P., et al.
Publicado: (2021)

Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer? ----A Pilot Study
por: Yang, Zhongyi, et al.
Publicado: (2013)

In vivo uptake of labelled oestradiol by benign and malignant tumours of the human breast.
por: O'Higgins, N. J., et al.
Publicado: (1973)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Oestradiol-17β plasma concentrations after intramuscular injection of oestradiol benzoate or oestradiol cypionate in llamas (Lama glama)
por: Cavilla, María V, et al.
Publicado: (2010)

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
por: Falahi, Fahimeh, et al.
Publicado: (2014)

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
por: Boonstra, Pieter A., et al.
Publicado: (2020)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

Comparison of diagnostic sensitivity of [(18)F]fluoroestradiol and [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
por: Chae, Sun Young, et al.
Publicado: (2020)

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
por: Koleva-Kolarova, R G, et al.
Publicado: (2015)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
por: Suzumura, Kazuhiro, et al.
Publicado: (2017)

The Uptake of Sporopollenin Exine Capsules and Associated Bioavailability of Adsorbed Oestradiol in Selected Aquatic Invertebrates
por: Chapman, Emma, et al.
Publicado: (2021)

In vitro imaging of bacteria using (18)F-fluorodeoxyglucose micro positron emission tomography
por: Heuker, Marjolein, et al.
Publicado: (2017)

Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
por: de Waal, Esther G. M., et al.
Publicado: (2016)

Prognosis of preoperative positron emission tomography uptake in hepatectomy patients
por: Kim, Jong Man, et al.
Publicado: (2018)

Serum Oestradiol-17β in Normal Women
por: England, P. C., et al.
Publicado: (1974)

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
por: Jones, Ella F., et al.
Publicado: (2019)

Publisher Correction: In vitro imaging of bacteria using (18)F-fluorodeoxyglucose micro positron emission tomography
por: Heuker, Marjolein, et al.
Publicado: (2019)

Myocardial uptake of F-18-fluorodeoxyglucose in whole body positron emission tomography studies
por: Tiwari, Bijaynath P, et al.
Publicado: (2012)

ɶstradiol Benzoate Therapy in Senile Vaginitis
por: Macgregor, T. N.
Publicado: (1938)

Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
por: Vidula, Mahesh K., et al.
Publicado: (2022)

Uptake of (18)F-fluoro-2-deoxyglucose in the Healthy Testes of Young Men as Assessed by Positron Emission Tomography/Computed Tomography; Including the Inter- and Intra-observer Variation
por: Meij-de Vries, A., et al.
Publicado: (2014)

Uptake of (18)FDG by a Hepatic Adenoma on Positron Emission Tomography
por: Stephenson, J. A., et al.
Publicado: (2011)

Similar outcomes for antenatally or postnatally acquired haemorrhages
por: de Vries, Linda S, et al.
Publicado: (2020)

Vascular uptake on (18)F-sodium fluoride positron emission tomography: precursor of vascular calcification?
por: den Harder, Annemarie M., et al.
Publicado: (2020)

Interim thymus and activation regulated chemokine versus interim (18)F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
por: Plattel, Wouter J., et al.
Publicado: (2020)

Imaging tumour hypoxia with positron emission tomography
por: Fleming, I N, et al.
Publicado: (2015)

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
por: Liu, Cheng, et al.
Publicado: (2022)

A method for comparing intra-tumoural radioactivity uptake heterogeneity in preclinical positron emission tomography studies
por: Grafström, Jonas, et al.
Publicado: (2015)

Quick Automatic Synthesis of Solvent-Free 16α-[(18)F] Fluoroestradiol: Comparison of Kryptofix 222 and Tetrabutylammonium Bicarbonate
por: Jiang, Xiao, et al.
Publicado: (2020)

Diagnostic and Prognostic Role of (18)F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
por: Fiz, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fgjak2lc1k62kjo52127alc47